Tenet Healthcare Corp (THC) Stock Down 5.0% but Still Overvalued -- GF Score: 79/100
Tenet Healthcare Corp (THC) shares recently dropped 5.0% to $178.00, yet its GF Value™ of $164.12 suggests the stock remains overvalued by 8.5%. Despite an "Above Average" GF Score™ of 79/100 indicating quality, insiders have sold $10.9 million worth of shares in the last three months, raising concerns about potential overpricing and future performance. Investors are advised to approach with caution due to the current overvaluation and insider selling activity.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
Tenet Healthcare Corporation (THC) is currently a frequently searched stock due to its recent performance and upcoming earnings expectations. The company holds a Zacks Rank #3 (Hold), suggesting it might perform in line with the broader market. Key factors like earnings estimate revisions, revenue growth forecasts, and valuation metrics are analyzed to provide insight into its potential near-term stock performance.
Tenet hospitals, Leapfrog spar over legal fees in hospital ratings case
Five Florida hospitals owned by Tenet Healthcare are seeking $10.5 million in legal fees and costs from The Leapfrog Group. This request comes after a judge ruled Leapfrog unfairly deflated the hospitals' ratings for not participating in a voluntary survey. Leapfrog argues the sum is "grotesquely inflated" and an attempt to financially ruin the nonprofit, which it states had only $8 million in revenue in 2024.
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA Healthcare
Bank of America's "Traffic Signals" report, based on Placer.ai foot traffic data, indicated positive trends for Tenet Healthcare (THC) in April, with its second-quarter foot traffic year-over-year growth exceeding consensus estimates. HCA Healthcare (HCA) showed neutral results, with its implied Q2 volume growth matching consensus. Other hospital companies like Universal Health Services (UHS) and Acadia Healthcare (ACHC) saw foot traffic growth fall below expectations.
Tenet Healthcare (THC) Principal Accounting Officer reports 2,584 RSUs on Form 3
Tenet Healthcare's Principal Accounting Officer, John Michael Grooms, has reported initial holdings of 2,584 unvested April 2026 time-based Restricted Stock Units (RSUs) on a Form 3 filing. These RSUs are scheduled to vest in two equal installments on April 15, 2028, and April 15, 2029, and will be settled in shares of common stock upon vesting. The filing indicates a neutral impact and sentiment regarding this transaction.
Tenet to Participate in the BofA Securities Health Care Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026, at 6:00 p.m. Eastern Time. A live webcast and audio archive of the event will be available through the investor relations section of Tenet’s website for 30 days. The company, headquartered in Dallas, is a diversified healthcare services provider, including United Surgical Partners International and various acute care and specialty hospitals, with a global business center in Manila, Philippines.
Tenet to webcast May 13 appearance at BofA health care conference
Tenet Healthcare Corporation (NYSE: THC) announced it is scheduled to present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026. A live webcast and audio archive of the presentation will be available through the investor relations section of Tenet’s website. The replay will remain accessible for 30 days after the event.
Tenet to Participate in the BofA Securities Health Care Conference
Tenet Healthcare Corporation is scheduled to present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026, at 6:00 p.m. Eastern Time. A live webcast and archive will be available on Tenet's investor relations website. Tenet Healthcare is a diversified healthcare services company operating a network of hospitals and outpatient facilities, and providing revenue cycle management services through its Conifer Health Solutions subsidiary.
Earnings call transcript: Tenet Healthcare beats Q1 2026 EPS expectations
Tenet Healthcare (THC) reported strong Q1 2026 results, significantly surpassing EPS expectations with $4.82 against a forecast of $4.16. Despite a slight revenue miss at $5.37 billion, the company achieved a robust adjusted EBITDA margin of 21.6% and generated $978 million in free cash flow. The positive earnings surprise led to a favorable market reaction, with the stock price increasing post-announcement, and the company reaffirmed its full-year 2026 guidance, emphasizing its focus on high-acuity services and operational efficiencies.
Tenet Healthcare Shines In Q1 2026 Earnings Call
Tenet Healthcare reported strong Q1 2026 results with $5.4 billion in net operating revenues, $1.162 billion in adjusted EBITDA, and robust free cash flow, indicating solid financial health. The company emphasized its operational momentum and disciplined capital allocation, with USPI continuing to be a strong growth driver. Despite facing headwinds from exchange enrollment, payer mix, and lower respiratory volumes, Tenet reaffirmed its full-year guidance, projecting approximately 10% normalized adjusted EBITDA growth.
Cost management, outpatient unit helped Tenet weather volume headwinds in Q1
Tenet Healthcare managed to navigate first-quarter volume pressures, unlike some of its peers, through effective cost management and a strategic focus on high-acuity service lines. Despite declines in acute care volumes due to a severe respiratory season and winter storms, Tenet posted stronger-than-expected earnings, buoyed by the strong performance of its ambulatory surgical unit, United Surgical Partners International. The company also reaffirmed its financial guidance for 2026, expecting revenues between $21.5 billion and $22.3 billion.
RBC Cuts Price Target on Tenet Healthcare to $236 From $277, Keeps Outperform Rating
RBC has revised its price target for Tenet Healthcare (THC) shares down to $236 from $277, while maintaining an "Outperform" rating on the stock. This adjustment comes despite several other recent analyst reports showing varied price target changes and the company reporting increased Q1 adjusted earnings and revenue, with raised 2026 EPS guidance. The article also notes Morgan Stanley trimmed its price target on Tenet Healthcare to $254 from $260, but kept an "Overweight" rating.
Tenet Healthcare Corporation (NYSE:THC) Q1 2026 Earnings Call Transcript
Tenet Healthcare Corporation reported strong Q1 2026 earnings, exceeding expectations with net operating revenues of $5.4 billion and adjusted EBITDA of $1.16 billion. Despite challenges like dynamic operating environments, payer mix shifts, and seasonal effects, the company reaffirmed its full-year guidance, emphasizing disciplined operations, expense management, and strategic investments in its USPI segment. Tenet also highlighted significant free cash flow generation and continued share repurchases, signaling confidence in its diversified asset mix and high-acuity strategy.
Tenet Healthcare Corporation 2026 Q1 - Results - Earnings Call Presentation (NYSE:THC) 2026-05-01
Tenet Healthcare Corporation (THC) has released its Q1 2026 earnings call presentation. The company reported an EPS of $4.82, beating estimates by $0.65, and revenue of $5.37 billion, which missed estimates by $27.83 million despite a 2.78% year-over-year increase. The provided slide deck accompanies the earnings call.
Tenet Healthcare Corporation $THC Stake Cut by Vanguard Group Inc.
Vanguard Group Inc. reduced its stake in Tenet Healthcare Corporation (NYSE:THC) by 1.7% in Q4, selling over 153,000 shares but still owning more than 10% of the company. Despite this, Tenet Healthcare reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and has a consensus "Moderate Buy" rating from analysts with an average price target of $250.56. Insider selling activity also occurred, with insiders selling a total of 46,517 shares worth approximately $10.94 million in the last three months.
Tenet Healthcare met Q1's volume curveballs with 'old-fashioned discipline'
Tenet Healthcare exceeded its first-quarter earnings expectations, with CEO Saum Sutaria attributing the success to the company's long-term strategy and "old-fashioned discipline" in navigating volume disruptions. Despite challenges like a soft flu season, winter storms, and a cybersecurity event, Tenet maintained strong margins through cost management and operational efficiencies. The company chose not to adjust its full-year 2026 guidance yet, despite the overperformance.
Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales
Tenet Healthcare (NYSE:THC) reported mixed Q1 results, with adjusted earnings surpassing expectations but sales slightly missing consensus. The company cited an unfavorable payer mix due to lower exchange admissions for soft Q1 sales and hospital segment growth limitations, despite strong growth in its ambulatory care segment. Tenet Healthcare also raised its fiscal 2026 adjusted earnings guidance but reaffirmed its sales guidance.
Vanguard files Schedule 13G: Tenet Healthcare (NYSE: THC) 5.26% stake
Vanguard Capital Management has filed a Schedule 13G, disclosing a 5.26% beneficial ownership stake in Tenet Healthcare (NYSE: THC), totaling 4,582,013 shares. The filing indicates that Vanguard has sole dispositive power over all these shares and sole voting power over 670,605 shares. This passive investment disclosure reflects holdings across various Vanguard affiliates and funds.
Transcript: Tenet Healthcare Q1 2026 Earnings Conference Call
Tenet Healthcare reported Q1 2026 net operating revenues of $5.4 billion and adjusted EBITDA of $1.16 billion, exceeding expectations with a 21.6% margin. The company saw strong performance in its USPI segment, driven by growth in joint replacements and ASC acquisitions, while the hospital segment also outperformed through disciplined expense management despite payer mix shifts and declines in exchange coverage. Tenet is investing in technology and AI to enhance operations and reaffirmed its full-year 2026 guidance, expecting 10% adjusted EBITDA growth and continued share repurchases.
Tenet Healthcare faces earnings test as hospital margins pressured
Tenet Healthcare (NYSE: THC) is facing its Q1 earnings test amid pressure on hospital margins across the sector. Analysts predict earnings of $4.16 per share on $5.39 billion revenue, a decline from the strong previous quarter, despite a strong buy rating from most analysts. Investors will be watching Tenet's ability to leverage its pricing advantage and strong ambulatory care segment to offset industry headwinds.
Tenet Healthcare Corp (THC) Stock Down 4.3% but Still Overvalued -- GF Score: 82/100
Tenet Healthcare Corp (THC) shares recently dropped 4.3% and are down 10.7% year-to-date, trading at $177.50. Despite this decline, the stock is considered "Modestly Overvalued" with a GF Value™ of $151.10, indicating a potential risk for investors. Insiders have sold $10.9 million in stock over the past three months, with no buying activity, suggesting a lack of confidence in the current valuation.
Tenet Healthcare Corporation (THC) Stock Analysis: Exploring A 45.4% Potential Upside
Tenet Healthcare Corporation (THC) presents a compelling investment case with a potential upside of 45.40%, according to analyst targets. Despite mixed technical indicators suggesting the stock might be overbought short-term, its robust revenue growth, strong return on equity, and significant free cash flow highlight its financial strength. The company's diversified service offerings also position it well for continued growth in the healthcare sector.
THC5423554 Bond Analysis — Key Metrics
This article provides key metrics and an overview of the Tenet Healthcare Corporation 6.125% bond (THC5423554) maturing on June 15, 2030. It details the issuer's profile, including its operational segments (Hospital Operations and Ambulatory Care), and lists crucial bond facts such as issue and maturity dates, coupon rate (6.13% fixed), and face value. The company, founded in 1969 and headquartered in Dallas, TX, is a healthcare services provider.
Tenet Healthcare Drops 5.8% Amid Sector-Wide Selling
Tenet Healthcare Corporation (THC) shares tumbled 5.8% to close at $177.38 due to a broad selloff affecting hospital operators across the sector. This decline was not driven by company-specific news but rather matched widespread weakness observed in peers like HCA (down 7.5%) and Universal Health Services (UHS) (down 4.4%), suggesting an industry-wide reassessment by investors. The synchronized downturn indicates that macro factors affecting the entire hospital operator universe, such as reimbursement trends or cost pressures, are likely influencing investor sentiment.
Tenet Healthcare Drops 5.8% Amid Sector-Wide Selling
Tenet Healthcare Corporation (THC) shares fell 5.8% to $177.38 on Friday, as a wider selloff impacted hospital operators. This decline, mirrored by HCA and Universal Health Services (UHS), suggests broad pressure across the healthcare facilities sector rather than company-specific issues, likely driven by macroeconomic factors affecting the entire industry. Investors are advised to monitor sector weakness and management commentary, as HCA's performance could indicate future trends for Tenet.
Tenet Healthcare Corporation $THC Position Increased by M&T Bank Corp
M&T Bank Corp significantly increased its stake in Tenet Healthcare Corporation by 1,944.8% in Q4 2025, now owning 104,304 shares valued at $20.7 million. This move comes as Tenet Healthcare reported strong quarterly earnings, beating analyst expectations for both EPS and revenue, and provided optimistic FY2026 guidance. Analysts have largely maintained a "Moderate Buy" consensus rating with a price target of $250.56, despite recent insider stock sales.
Tenet Healthcare Corp stock (US88033G4073): Why Google Discover changes matter more now
Google's 2026 Discover Core Update is significantly changing how investors receive financial news, pushing insights on stocks like Tenet Healthcare Corp (US88033G4073) directly to their mobile feeds. This mobile-first approach leverages user activity to deliver tailored content on hospital trends, ambulatory care growth, and earnings, emphasizing E-E-A-T principles for concise, actionable information. For Tenet Healthcare Corp investors, this means proactive updates on strategic divestitures, USPI acquisitions, and performance metrics, providing a decisive edge in tracking the company's shift towards ambulatory care and its overall financial health.
Tenet Healthcare (THC) Declines More Than Market: Some Information for Investors
Tenet Healthcare (THC) shares declined by 2.74% in the latest trading session, underperforming the S&P 500. The company is set to release its earnings report on April 30, 2026, with analysts expecting an EPS of $4.19 and revenue of $5.39 billion. THC currently holds a Zacks Rank #3 (Hold) and is trading at a Forward P/E ratio of 11.37, aligning with its industry average.
KBC Group NV Boosts Stake in Tenet Healthcare Corporation $THC
KBC Group NV significantly increased its stake in Tenet Healthcare Corporation by 368.5% in Q4, acquiring an additional 41,885 shares and bringing its total to 53,250 shares valued at $10.58 million. Institutional investors now collectively own 95.44% of the company. Wall Street analysts maintain a "Moderate Buy" rating with a consensus price target of $250.56, following strong Q4 earnings where Tenet Healthcare exceeded revenue and EPS expectations.
Tenet Healthcare Corp stock (US88033G4073): Why mobile-first delivery is suddenly worth a closer loo
Google's 2026 Discover Core Update is changing how retail investors access information on Tenet Healthcare Corp (THC), prioritizing mobile-first content like hospital trends, ambulatory care growth, and Conifer revenue directly in their feeds without searching. This shift provides an edge by offering proactive, tailored insights on THC's performance, particularly its ambulatory care segment via USPI, and its revenue cycle management subsidiary, Conifer. The update emphasizes visual, credible content optimized for mobile, helping investors track catalysts and risks for better decision-making in the healthcare sector.
Tenet Healthcare Corp stock (US88033G4073): Why mobile-first delivery is suddenly worth a closer loo
Google's 2026 Discover Core Update is revolutionizing how retail investors access information on Tenet Healthcare Corp (THC) by delivering tailored insights directly to mobile feeds without the need for traditional searches. This mobile-first approach aggregates analysis on hospital trends, ambulatory care growth, and Conifer revenue, leveraging user activity to proactively surface relevant content. The update allows investors to stay ahead of market catalysts and risks, optimizing their decision-making process for THC stock.
Tenet Healthcare Corporation (THC) is attracting investor attention: Here is what you should know
This article highlights that Tenet Healthcare Corporation (THC) is gaining investor attention. It suggests readers should be aware of key information about the company. The content provided is minimal and doesn't elaborate on specific reasons for this attention or what investors should know.
[ARS] TENET HEALTHCARE CORP SEC Filing
This article announces an SEC ARS filing by TENET HEALTHCARE CORP (THC) on April 16, 2026, with a low impact and neutral sentiment. The filing details are available as a PDF document on SEC EDGAR. The page also provides an overview of THC's stock information, including market cap, industry, and recent news and SEC filings.
Cantor Fitzgerald reiterates Tenet Healthcare stock rating on volumes By Investing.com
Cantor Fitzgerald has reiterated an Overweight rating and a $245.00 price target for Tenet Healthcare (THC), based on survey data suggesting a 2.3% year-over-year increase in outpatient surgeries, up from 1.9% in Q4 2025. This trend aligns with consensus expectations for both Tenet Healthcare and HCA Healthcare, with the firm indicating that volume growth is unlikely to exceed current guidance. The report also highlights HCA Healthcare's strong performance, recognized by analysts including Cantor Fitzgerald and TD Cowen, who have maintained or raised price targets for HCA.
Tenet CIO to retire at year end
Tenet Healthcare's Chief Information Officer, Paola Arbour, is set to retire at the end of 2026 after nearly seven years with the company. She will remain with Tenet part-time until early 2028 to assist with the transition. Arbour's retirement coincides with Tenet's efforts to improve margins by focusing on high-acuity services and integrating its revenue cycle management subsidiary, Conifer Health Solutions.
Is It Time To Reconsider Tenet Healthcare (THC) After Recent Share Price Pullback?
This article evaluates Tenet Healthcare (THC) after a recent share price pullback, suggesting it may be undervalued. Using a Discounted Cash Flow (DCF) analysis, the intrinsic value is estimated at $627.95, representing a significant discount from its current price of $192.99. The company also appears undervalued based on its Price-to-Earnings (P/E) ratio compared to industry averages and its proprietary Fair Ratio.
A Look At Tenet Healthcare (THC) Valuation After Earnings Beat And Softer Guidance Update
Tenet Healthcare (THC) recently reported strong quarterly revenue growth and beat EPS expectations, despite providing softer guidance than peers. While the stock has seen a recent pullback, it still boasts significant long-term returns. Analysts suggest the company is undervalued, with a fair value of $240.60 against its current trading price of $195.24, highlighting its evolution into a broader healthcare platform with focus on outpatient services and behavioral health.
Tenet Healthcare Tops Volume Chart With $290M Clash as Bulls Meet Bearish Guidance
Tenet Healthcare (THC) shares declined by 3.28% despite topping daily trading volume with $290 million, indicating heightened investor attention and liquidity. This drop occurred despite strong Q4 2025 earnings which surpassed analyst forecasts, suggesting investors were reacting to bearish forward-looking guidance for 2026, particularly a projected 20% reduction in exchange marketplace enrollment. The high trading volume amidst price decline signals a significant debate between bullish investors focusing on operational strength and a strategic M&A approach, and bearish investors concerned about regulatory headwinds.
Tenet Healthcare Tops Volume Chart With $290M Clash as Bulls Meet Bearish Guidance
Tenet Healthcare Corp. saw its shares close lower despite ranking first in daily trading volume with a transaction value of $290 million, indicating a significant divergence between high trading activity and a downward price movement. This occurred after its fiscal fourth-quarter earnings report, which, despite surpassing analyst forecasts, was overshadowed by cautious forward-looking guidance for 2026 regarding regulatory and macroeconomic pressures, including an expected 20% reduction in exchange marketplace enrollment. The market is weighing the company's strong operational performance and asset acquisition strategy against these potential future headwinds.
Tenet Healthcare Tops Volume Chart With $290M Clash as Bulls Meet Bearish Guidance
Tenet Healthcare's shares fell by 3.28% on April 10, 2026, despite topping the daily trading volume chart with $290 million. This decline occurred after the company reported strong Q4 2025 earnings but issued cautious 2026 guidance, including a projected 20% reduction in exchange marketplace enrollment. The high trading volume amidst a price drop reflects a market debate between the company's robust operational performance and its forward-looking risks.
Tenet Healthcare Corp (THC) Stock Down 3.3% but Still Overvalued -- GF Score: 83/100
Tenet Healthcare Corp (THC) shares dropped 3.3% to $195.24, yet the stock remains "Modestly Overvalued" according to GuruFocus' GF Value™ of $150.58. The company has a strong GF Score™ of 83/100, driven by a high momentum rating, but insider selling of $10.9 million in the last three months without any buying activity suggests a lack of confidence from those close to the company. Investors are advised to exercise caution due to the significant difference between the market price and the intrinsic value.
Tenet Healthcare's Paola Arbour to Retire as EVP & CIO, Transition to Part-Time Role
Tenet Healthcare announced that Paola Arbour, Executive Vice President and Chief Information Officer, will retire from her full-time role on December 31, 2026. She will then transition to a part-time position until April 1, 2028, to provide transition services. This information was based on an SEC filing from April 10, 2026.
Tenet Healthcare (NYSE: THC) CIO Paola Arbour sets 2026 retirement, part-time role to 2028
Tenet Healthcare announced that its Executive Vice President and Chief Information Officer, Paola Arbour, will retire from her CIO role on December 31, 2026. She will then transition to a part-time, non-executive position until April 1, 2028, to provide transition support. During this period, Ms. Arbour will receive a weekly salary of $820, remain eligible for her 2026 bonus, and her equity awards and benefits will continue under existing terms.
Tenet Healthcare Surges to Top Spot in Daily Trading Volume After Earnings Exceed Expectations, Triggering $340 Million Upswing
Tenet Healthcare Corp. (THC) experienced a significant surge in stock price and trading volume following strong fourth-quarter 2025 results that exceeded analyst expectations. The company reported impressive earnings per share and revenue, along with robust consolidated adjusted EBITDA and free cash flow. Despite potential regulatory challenges, Tenet provided an optimistic outlook for 2026, driven by its strategic focus on high-acuity procedures and commitment to shareholder returns.
Zacks Industry Outlook Features Tenet Healthcare, Universal Health Services, Acadia Healthcare, and Community Health Systems
Zacks Equity Research has analyzed the medical-hospital sector, highlighting companies like Tenet Healthcare, Universal Health Services, Acadia Healthcare, and Community Health Systems. The industry faces evolving patient demands and cost pressures, driving investments in technology, efficiency, and strategic consolidation. Analysts are optimistic about the sector's growth prospects, with several stocks showing favorable trends and positive earnings estimate revisions.
Possible Bearish Signals With Tenet Healthcare Insiders Disposing Stock
This article examines recent insider selling at Tenet Healthcare, noting that multiple insiders have disposed of stock over the past year. While some selling is normal, the volume and recent activity warrant attention, especially given the company's P/E ratio and debt levels. Investors may want to consider this as a potentially bearish signal.
Zacks Industry Outlook Features Tenet Healthcare, Universal Health Services, Acadia Healthcare, and Community Health Systems
Zacks Equity Research has analyzed the Medical-Hospital sector, highlighting key trends like the shift to outpatient care, rising demand, cost pressures, technological adoption, and consolidation through M&A. The sector maintains a positive outlook, with specific recommendations for Community Health Systems, Tenet Healthcare, Universal Health Services, and Acadia Healthcare, citing their strategic initiatives and financial performance. The industry is adapting to changing healthcare landscapes by focusing on efficiency, technology, and strategic partnerships.
Tenet to Report its First Quarter 2026 Results on April 30th
Tenet Healthcare Corporation (NYSE: THC) announced it will release its first-quarter 2026 financial results before the market opens on Thursday, April 30, 2026. This will be followed by a conference call at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). A live webcast and audio archive of the call will be accessible through the investor relations section of Tenet’s website.
THC Financials: Revenue Breakdown, Margins & Competitor Comparison
This article analyzes Tenet Healthcare Corp's (THC) financials, detailing its revenue breakdown, profitability margins, and competitor comparison. The largest portion of its revenue comes from hospital operations, while it maintains strong gross and operating margins. The article also benchmarks THC against competitors like UHS and CHE, highlighting its market position and efficiency.
Allspring Global Investments Holdings LLC Has $68.69 Million Stock Holdings in Tenet Healthcare Corporation $THC
Allspring Global Investments Holdings LLC reduced its stake in Tenet Healthcare Corporation (NYSE:THC) by 14.9% in Q4, now holding 344,388 shares valued at $68.69 million. Other hedge funds also adjusted their positions, and institutional investors own 95.44% of the company's stock. Analysts generally maintain a "Moderate Buy" rating with an average price target of $250.56, following strong Q4 earnings where Tenet Healthcare exceeded EPS and revenue estimates and provided positive FY2026 guidance.
